Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New ...
Journal of Nuclear Medicine February 2025, jnumed.124.268387; DOI: https://doi.org/10.2967/jnumed.124.268387 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268612; DOI: https://doi.org/10.2967/jnumed.124.268612 A key challenge in advancing RPTs is variability in AD ...
Journal of Nuclear Medicine February 2025, jnumed.124.268079; DOI: https://doi.org/10.2967/jnumed.124.268079 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268762; DOI: https://doi.org/10.2967/jnumed.124.268762 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268640; DOI: https://doi.org/10.2967/jnumed.124.268640 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268586; DOI: https://doi.org/10.2967/jnumed.124.268586 ...
Journal of Nuclear Medicine February 2025, jnumed.124.269024; DOI: https://doi.org/10.2967/jnumed.124.269024 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Journal of Nuclear Medicine February 2025, jnumed.124.267809; DOI: https://doi.org/10.2967/jnumed.124.267809 ...
Radiopharmaceutical therapy (RPT), with its targeted delivery of cytotoxic ionizing radiation, demonstrates significant potential for treating a wide spectrum of malignancies, with particularly unique ...